Revenue and Segment Information - Additional Information (Detail) $ in Millions |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2026
USD ($)
Segment
|
Mar. 31, 2025
USD ($)
|
|
| Revenue from Contract with Customer [Abstract] | ||
| Research development and clinical trials expenses | $ | $ 2.2 | $ 1.3 |
| Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description | The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the Company’s chief operating decision maker, or decision-making group (the “CODM”), in deciding how to allocate resources and assess performance. The CODM of the Company is the Chief Executive Officer. The CODM assesses performance and allocates resources based on the Company’s consolidated statements of operations and the Company’s operations are managed on a consolidated basis to decide where to allocate and invest additional resources within the business to continue growth. The CODM also utilizes the consolidated balance sheet for resource allocation and segment asset information is not provided to the CODM to allocate resources. As a single reportable segment entity, the Company’s segment performance measure is net income (loss). Significant segment expenses, as provided to the CODM, are presented below (in thousands): | |
| Number of reportable segment | Segment | 1 | |
| Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] | srt:ChiefExecutiveOfficerMember | |